Licensed Pharmacies•
Fully Online Care•
Free Expedited Delivery•
Dedicated Clinical Team•
HSA/FSA Accepted•
Same-Day Doctor Visits•

Ozari vs Henry Meds: $179/mo vs Ozari One at $86/mo, Billed Quarterly

Published August 9, 2026

Henry Meds and Ozari agree on the argument and disagree on the number. Both sell compounded GLP-1s through licensed US pharmacies. Both bundle the provider visit, the medication, the supplies, and the follow-up into a single flat price with no membership fee. Henry's own FAQ says its GLP-1 plans start at $179/month. Ozari One semaglutide is $86/mo, billed $258 every 3 months. Same structure, $93 apart, every month. Ozari One ships to every state except California; California patients use Ozari Select, $145/mo billed quarterly for semaglutide or $199/mo for tirzepatide.

What Henry Meds Publicly Lists

As of August 2026, henrymeds.com states that GLP-1 pricing "varies by treatment plan and dosing, but starts at $179/month," and that this "includes the cost of your provider visits, medication, supplies, and ongoing support." Henry offers compounded semaglutide, liraglutide, and tirzepatide, in both injectable and oral formats.

Ozari's true-cost tracker, verified July 2026, has listed additional detail: injectable semaglutide at $247–$297/month, with the $247 rate requiring a 12-month commitment and $297 for month-to-month; a $147 first month; oral semaglutide at $199/month; oral tirzepatide at $299/month; and consult fees of $49–$99 on some plans. Henry's site does not publish a full per-plan price grid on its treatment page, so verify current pricing for your specific plan directly with Henry Meds.

Henry's disclosure practices deserve specific praise. Its GLP-1 page states outright that compounded medications "do not undergo pre-market review or an FDA-approval process," that trial data from approved drugs should not be transferred to compounded versions, and that it "exclusively works with licensed compounding pharmacies in the United States" (503A pharmacies and 503B outsourcing facilities). Henry is LegitScript certified. Two operational notes from its FAQ: eligibility runs from age 18 to 70, and multi-month plans may require paying out the balance if you cancel early for non-medical reasons.

How the Models Compare

This is the closest structural match in the batch. No membership fee on either side. One bill on either side. Compounded medication from disclosed, licensed US pharmacies on either side. Henry adds oral tablet formats — a real option for needle-averse patients that Ozari's injectable lineup doesn't cover — and publishes a peer-reviewed retrospective study of its own patient outcomes, which few telehealth brands bother to do.

The differences are the entry price, the commitment mechanics, and the ceiling. Henry's lowest advertised number is $179/month, its tracked injectable semaglutide rates sit at $247–$297, and the cheaper rate binds you for twelve months. Ozari One is $86/mo billed quarterly with no annual lock; Ozari Select is $145/mo quarterly or $175/mo monthly.

The 12-Month Math

Henry, at the advertised floor: $179 × 12 = $2,148, assuming your plan and dose stay at the starting price.

Henry, at the tracker-recorded injectable semaglutide rates: $247 × 12 = $2,964 with a 12-month commitment, or $297 × 12 = $3,564 month-to-month. A $147 first month, where offered, trims those figures slightly.

Ozari's published year one:

  • Semaglutide: Ozari One at $258 every 3 months, $258 × 4 = $1,032
  • Tirzepatide: Ozari One at $375 every 3 months, $375 × 4 = $1,500

Even against Henry's best advertised number, Ozari One's semaglutide year runs $2,148 − $1,032 = $1,116 less. Against the tracked committed rate, the gap is $2,964 − $1,032 = $1,932. Ozari One's tirzepatide year ($1,500) also comes in under Henry's tracked oral tirzepatide rate ($299 × 12 = $3,588).

A note from Johanna Galyen, APRN, FNP: We ask patients to prove a medication to themselves before they prepay for it. Twelve months is a long promise when you are still in weeks four through eight, where nausea and dose adjustments do most of their sorting. Run at least one full titration step on month-to-month billing before locking a committed rate anywhere. And if you transfer to us from a flat-rate plan, send your fill dates along with your doses — the calendar tells us as much as the milligrams do.

Key Comparison Table

| | Henry Meds | Ozari Health |

For the full 12-month breakdown of Henry Meds's pricing, including membership fees, dose escalation and the first-refill price, see the Henry Meds true-cost page. |---|---|---| | Pricing model | Flat all-in monthly, varies by plan/dose | Flat all-in; Ozari One billed quarterly, Ozari Select monthly to annual | | Semaglutide price | From $179/mo advertised; $247–$297/mo injectable per Ozari tracker | Ozari One $86/mo billed quarterly; Ozari Select $145/mo quarterly or $175/mo monthly | | Tirzepatide price | Offered; oral listed at $299/mo per Ozari tracker | Ozari One $125/mo billed quarterly; Ozari Select $199/mo quarterly or $235/mo monthly | | Membership fee | None | None | | Pharmacy disclosure | Licensed US 503A/503B compounding pharmacies, disclosed | Licensed 503A US compounding pharmacies | | Clinical oversight | Provider visits included; $30 medical consultation fee non-refundable once prescribed | Licensed providers via Wasef Health, PC or Arora Health | | Certification | LegitScript certified | LegitScript certified | | Commitment | 12-month commitment for lowest tracked rate; payout on early cancel | No long-term contract: Ozari One billed every 3 months, cancel before the next shipment; Ozari Select monthly, quarterly, semi-annual or annual |

Before you pay any provider, check it against the eight red flags that rule out a GLP-1 provider.

Henry Meds models the disclosure every compounded-GLP-1 seller should offer. Many do not. Avoid any provider that:

  • Sells GLP-1s without a prescription or provider review
  • Uses "generic Ozempic" language — no US generic semaglutide exists
  • Claims its compounded medications are FDA-approved
  • Won't name its dispensing pharmacy
  • Offers "research use only" peptides for human use
  • Guarantees a specific number of pounds lost

How to Cancel Henry Meds

Henry's help center directs cancellation and reactivation questions to its support team at ask@henrymeds.com or (909) 787-2342; check your patient portal account page first for a self-serve cancel option, then email or call if you don't see one. The refund rules are laid out in Henry's published Refunds, Returns & Replacements Policy. Per that policy as of August 2026: subscription fees are generally non-refundable once billed, dispensed medication is final sale, and the $30 medical consultation fee is non-refundable once a prescription has been issued. The notable exception covers prepaid multi-month plans — if a licensed provider documents that continuing therapy is medically contraindicated and Henry's clinical team approves, a prorated refund of the unused subscription period is available, less any processing fee. Henry's FAQ also notes multi-month plans may require paying out the remaining balance if canceled early for non-medical reasons. Cancel ahead of your billing date, put the request in writing even if you call, and screenshot the confirmation. Ozari's cancellation terms are published on its refund policy page: https://www.ozarihealth.com/refund-policy

Frequently Asked Questions

How much does Henry Meds GLP-1 treatment cost?

Henry's FAQ says plans start at $179/month, all-inclusive, varying by treatment and dose. Ozari's tracker has recorded injectable semaglutide at $247–$297/month. Verify your plan's current price directly with Henry Meds.

Does Henry Meds charge a membership fee?

No. Like Ozari, Henry bundles provider visits, medication, supplies, and support into one flat price with no separate membership charge.

Is there a commitment at Henry Meds?

Per Ozari's tracker, the lower $247/month injectable semaglutide rate has required a 12-month commitment. Henry's FAQ notes multi-month plans may require paying out the remaining balance if canceled for non-medical reasons.

Are Henry's medications FDA-approved?

No, and Henry says so plainly: its compounded GLP-1s do not go through FDA pre-market review. They are prepared by licensed US 503A pharmacies and 503B outsourcing facilities on individual prescriptions.

How does Ozari's price compare over a year?

Ozari One semaglutide: $1,032 year one ($258 billed every 3 months, $258 × 4). Henry's advertised floor works out to $2,148, and tracked injectable rates to $2,964–$3,564. Confirm current figures with both companies.

Who is eligible at each?

Henry accepts ages 18–70, subject to provider review. Ozari serves all 50 states via intake confirmation, with a licensed independent provider reviewing every case before any prescription.

How do I cancel Henry Meds?

Check your patient portal for a cancel option, or contact ask@henrymeds.com / (909) 787-2342 before your billing date. Subscription fees and dispensed medication are non-refundable; prepaid multi-month plans are prorated only with documented medical need approved by Henry's clinical team.

Is Henry Meds legitimate?

Henry Meds requires licensed provider review and discloses that compounded medications are not FDA-approved, per its published pages. Henry Meds states it holds LegitScript certification; you can confirm that at legitscript.com and check its pharmacy licensure before ordering.

This article is for informational purposes only and is not medical advice. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Always consult a licensed healthcare provider before starting any weight-loss medication. Ozari Health connects patients with licensed independent providers who determine whether treatment is appropriate.

Sources

Related Articles